Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Wenzel

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Dermatology : EJD|April 30, 2002
Scleroderma and malignancy. Mechanisms of interrelationshipJoerg Wenzel
Nature Reviews. Rheumatology|August 11, 2019
Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategiesJoerg Wenzel
Drugs|June 19, 2014
Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatmentThorsten Hornung, Joerg Wenzel
The Journal of Investigative Dermatology|April 18, 2008
An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis"Joerg Wenzel, Thomas Tüting
Experimental Dermatology|April 18, 2007
Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approachesJoerg Wenzel, Thomas Tüting
Experimental Dermatology|July 8, 2020
Cutaneous lupus erythematosus: The impact of self-amplifying innate and adaptive immune responses and future prospects of targeted therapiesTanja Fetter, Joerg Wenzel
Frontiers in Immunology|June 14, 2019
Interleukin-36 in Infectious and Inflammatory Skin DiseasesAnna-Lena Buhl, Joerg Wenzel
Expert Review of Clinical Pharmacology|January 23, 2016
Upcoming therapeutic targets in cutaneous lupus erythematousAnna Sophie Klaeschen, Joerg Wenzel
The Journal of Investigative Dermatology|November 10, 2021
Targeted Therapies in Autoimmune Skin DiseasesChristine Braegelmann, Dennis Niebel, Joerg Wenzel
Handbook of Experimental Pharmacology|December 12, 2007
Toll-like receptor-agonists in the treatment of skin cancer: history, current developments and future prospectsJoerg Wenzel, Damia Tormo, Thomas Tüting
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Dermatology : EJD|April 30, 2002
Scleroderma and malignancy. Mechanisms of interrelationshipJoerg Wenzel
Nature Reviews. Rheumatology|August 11, 2019
Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategiesJoerg Wenzel
Drugs|June 19, 2014
Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatmentThorsten Hornung, Joerg Wenzel
The Journal of Investigative Dermatology|April 18, 2008
An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis"Joerg Wenzel, Thomas Tüting
Experimental Dermatology|April 18, 2007
Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approachesJoerg Wenzel, Thomas Tüting
Experimental Dermatology|July 8, 2020
Cutaneous lupus erythematosus: The impact of self-amplifying innate and adaptive immune responses and future prospects of targeted therapiesTanja Fetter, Joerg Wenzel
Frontiers in Immunology|June 14, 2019
Interleukin-36 in Infectious and Inflammatory Skin DiseasesAnna-Lena Buhl, Joerg Wenzel
Expert Review of Clinical Pharmacology|January 23, 2016
Upcoming therapeutic targets in cutaneous lupus erythematousAnna Sophie Klaeschen, Joerg Wenzel
The Journal of Investigative Dermatology|November 10, 2021
Targeted Therapies in Autoimmune Skin DiseasesChristine Braegelmann, Dennis Niebel, Joerg Wenzel
Handbook of Experimental Pharmacology|December 12, 2007
Toll-like receptor-agonists in the treatment of skin cancer: history, current developments and future prospectsJoerg Wenzel, Damia Tormo, Thomas Tüting
Pageof 9